OR WAIT null SECS
June 17, 2022
FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.
June 09, 2022
Roche has received approval from the European Commission for Lunsumio (mosunetuzumab), the first CD20xCD3 T-cell engaging bispecific antibody for treating follicular lymphoma.
June 08, 2022
The acquisition grants Bristol Myers Squibb access to the company's oncology pipeline and lead candidate, repotrectinib.
Eli Lilly and Company plans to build two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.
June 01, 2022
GSK’s acquisition of Affinivax will give the company access to their portfolio of next-generation pneumococcal vaccines.
May 18, 2022
Pfizer and BioNTech’s COVID-19 vaccine has been granted EUA for booster doses in children five through 11 years of age.
May 16, 2022
Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.
May 06, 2022
FDA is limiting the use of Janssen’s COVID-19 vaccine to certain individuals.
May 05, 2022
Purolite has received the Queen’s Award for Enterprise in the International Trade category.
May 02, 2022
Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.